(Q57712219)

English

Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial

article by Nasrin Sharifi et al published 27 June 2014 in Endocrine

In more languages

Statements

scholarly article

0 references

Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial (English)

0 references

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

fatty liver disease

0 references

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

object named as

Reza Amani

2

0 references

Eskandar Hajiani

object named as

Eskandar Hajiani

3

0 references

author name string

Nasrin Sharifi

1

0 references

Bahman Cheraghian

4

0 references

publication date

27 June 2014

0 references

0 references

47

0 references

1

0 references

70-80

0 references

Vitamin D deficiency

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Update in vitamin D

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

International physical activity questionnaire: 12-country reliability and validity

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Mechanisms of disease progression in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Vitamin D and the vitamin D receptor in liver pathophysiology

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Role of transforming growth factor beta in human disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Serum TGF-β, Serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Vitamin D and diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Serum vitamin D concentrations and unexplained elevation in ALT among US adults

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Meta-analysis: vitamin D and non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0336-5

21 January 2018

Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the vitamin D status of the US population

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between pro-resorptive inflammatory cytokines and the effect of high dose vitamin D supplementation on their circulating concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shedding new light on vitamin D and fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum transforming growth factor-beta levels in patients with vitamin D deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends

1 reference

https://pubmed.ncbi.nlm.nih.gov/24968737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12020-014-0336-5

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57712219&oldid=2213596975"